BioNTech SE
BNTXNASDAQHealthcare● Active
$85.50
$-2.58(-2.93%)
Market Cap$21.6B
P/E Ratio—
52W High$124
52W Low$79.52
BioNTech SE（BNTX）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · BNTX · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $14.83B | $16.78B | $16.55B | $14.06B | $2.07B |
| Net Receivables | $0.98B | $1.52B | $2.34B | $7.15B | $12.38B |
| Inventory | $0.11B | $0.28B | $0.36B | $0.44B | $0.50B |
| Total Current Assets | $16.14B | $18.80B | $19.53B | $21.92B | $15.07B |
| PP&E Net | $1.29B | $1.18B | $0.97B | $0.82B | $0.52B |
| Goodwill | $0.37B | $0.38B | $0.36B | $0.06B | $0.06B |
| Intangible Assets | $1.61B | $0.79B | $0.80B | $0.16B | $0.14B |
| Total Assets | $21.98B | $22.53B | $23.01B | $23.28B | $15.83B |
| Liabilities | |||||
| Short-Term Debt | $0.05B | $0.04B | $0.03B | $0.04B | $0.13B |
| Accounts Payable | $0.53B | $0.43B | $0.35B | $0.20B | $0.16B |
| Total Current Liabilities | $2.14B | $2.52B | $2.07B | $2.95B | $3.48B |
| Long-Term Debt | $0.03B | $0.21B | $0.19B | $0.18B | $0.17B |
| Total Liabilities | $2.76B | $3.12B | $2.76B | $3.22B | $3.94B |
| Stockholders Equity | |||||
| Retained Earnings | $17.95B | $19.10B | $19.76B | $18.83B | $9.88B |
| Total Stockholders Equity | $19.22B | $19.41B | $20.25B | $20.06B | $11.89B |
| Total Liab & Equity(computed) | $21.98B | $22.53B | $23.01B | $23.28B | $15.83B |
| Debt Summary | |||||
| Total Debt | $0.27B | $0.25B | $0.22B | $0.21B | $0.30B |
| Net Debt | ($7.40B) | ($9.51B) | ($11.44B) | ($13.66B) | ($1.39B) |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · EUR · B
深入了解BioNTech SE
关于BioNTech SE（BNTX）资产负债表
BioNTech SE总资产$21.98B，现金及短期投资$14.83B，总负债$2.76B，总债务$0.27B，股东权益$19.22B。
常见问题
BNTX · 4 问BioNTech SE总债务$0.27B，净债务($7.40B)。
BNTX total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10